Market Pulse
KIS quote snapshot · Sep 21, 2026 13:00 KST · KIS quote snapshots + ECOS · 30 min refresh
KOSPI
7,018.85
+124.62 (+1.81%)
KOSDAQ
836.00
+8.88 (+1.07%)
KOSPI 200
1,114.33
+24.10 (+2.21%)
USD/KRW
1,383.30
028260KOSPI·Oct 29, 2025
Biologics business accounts for 73% of operating profit
Mirae Asset Securities published a company analysis report on Samsung C&T Corporation (028260) titled "Biologics business accounts for 73% of operating profit".
Summary
Covers Samsung C&T Corporation (028260).
Covered stock
More on 028260
Strong results backed by a solid business portfolioMirae Asset Securities · Jul 30, 2026Multiple tailwinds from Samsung ElectronicsMirae Asset Securities · Jun 23, 2026One-off cost reflected; expansion into energy continuesMirae Asset Securities · Apr 30, 2026Head Start in Nuclear Energy BusinessKB Securities · Mar 13, 2026Greater Earnings, Better Shareholder Returns, Stronger Nuclear Energy BusinessKB Securities · Feb 03, 2026Steady rise in both operating and asset valueMirae Asset Securities · Jan 30, 2026Ample Investment Merit Besides Rising Equity ValueKB Securities · Jan 13, 2026Weak E&C results, but potential for recoveryMirae Asset Securities · Jul 31, 2025In-line 1Q25 results likely despite weak E&C revenueMirae Asset Securities · Apr 24, 2025